Nanotechnology in Oncology: Research, Diagnosis and Therapy
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: 10 November 2024 | Viewed by 30
Special Issue Editor
Interests: circulating biomarkers; proteomics; nanomaterials; oncology; diagnosis; prognosis; prediction; therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Throughout the world, cancer is one of the leading causes of death and morbidity. Cancer is characterized by uncontrolled, random cell division and invasiveness. For these reasons, it is important to ensure earlier detection and treatment of cancers to reduce disease spread and mortalities. Nanotechnology-based diagnostic methods are being developed as promising tools for real-time, convenient, and cost-effective cancer diagnosis and detection. Furthermore, the advent of nanotechnology has revolutionized the area of cancer treatment.
This Special Issue aims to cover recent progress in both diagnostic and therapeutic cancer strategies based on nanotechnology. The format of welcomed articles includes full papers, communications, and reviews.
Potential topics include, but are not limited to, the following:
- Nanotechnology in cancer diagnosis: nanoparticles for tumor imaging (active and passive targeting), biomarker screening methods based on nanoparticles, nanotechnology for the detection of extracellular cancer biomarkers (proteins, circulating tumor DNA (ctDNA), microRNA, DNA methylation, extracellular vesicle detection), nanotechnology for the detection of cancer cells (circulating tumor cells (CTCs), detection through cell surface protein recognition, detection based on mRNA);
- Nanotechnology in cancer therapy: nanoparticles for targeted drug delivery (mechanism of NPs in overcoming drug resistance), nanoparticles in immunotherapy, nanoparticles for cryosurgery, photothermal therapy (PTT) and photodynamic therapy (PDT) based on nanoparticles, nanoparticles for radiotherapy;
- Advantages and disadvantages of nanotechnology in cancer diagnosis and therapy;
- Challenges in the clinical application of nanotechnology for cancer diagnosis and therapy.
Dr. Cristina Núñez González
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials nanotechnology
- nanomedicine
- cancer
- oncology
- diagnosis
- molecular imaging
- treatment
- therapy
- theranostics
